Oct 4 |
Capricor stock rallies 20% on DMD data presentation update
|
Oct 4 |
Capricor Therapeutics to Present Long-Term Data from HOPE-2 Open Label Extension Study at 2024 World Muscle Society Congress
|
Oct 3 |
Is Capricor Therapeutics, Inc. (CAPR) the Best Russell 2000 Stock to Buy According to Analysts?
|
Oct 1 |
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
|
Sep 29 |
Wall Street Breakfast: The Week Ahead
|
Sep 26 |
High Growth Tech Stocks To Watch In September 2024
|
Sep 25 |
Dow Tumbles Over 200 Points; CERo Therapeutics Shares Jump
|
Sep 25 |
Nvidia, Alibaba, Capricor Therapeutics, TSMC, Tesla: Why These 5 Stocks Are On Investors' Radars Today
|
Sep 24 |
Capricor: DMD Treatment Focus With Deramiocel Is Likely To Pay Off
|
Sep 24 |
Capricor surges on plans to seek FDA approval for lead asset
|